baha the information company

baha ist einer der weltweit führenden Anbieter von Echtzeit-Marktdaten, Finanznachrichten, Technologie und Lösungen für die Finanzbranche. baha bietet Echtzeit-Marktterminals für Professionelle Nutzer, globale Finanzmarktdaten für über 12 Millionen Finanzinstrumente an mehr als 150 Börsen sowie aktuelle Nachrichten rund um die Uhr mit globaler Berichterstattung mit öffentlichem Webportal und gratis mobilen Apps. Von insgesamt rund 200 Real-Time Datenanbietern weltweit wurden nur Reuters 1851, Bloomberg 1981 und nun in 2021 baha nach dem Gründer benannt.

Rodinia Oil Corp./ CA77487N1096 /

03.04.2024 15:30:34	Diff. -	Volumen	Geld-	Brief-	Tageshoch	Tagestief
0.0000USD	-	321'000 Umsatz: .3210	-Geld Vol: -	-Brief Vol: -	0.0000	0.0000

GlobeNewswire 23:13 SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of Clinical Onc...

TeleTrader 23:13 SEC approves Ethereum ETFs

GlobeNewswire 23:11 Special Olympics Florida and Orlando Health Announce Five-Year Partnership

GlobeNewswire 23:10 Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-10...

GlobeNewswire 23:09 Ivy Brain Tumor Center announces Phase 0/2 clinical readout of niraparib indicating significant impr...

GlobeNewswire 23:06 G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (A...

GlobeNewswire 23:05 Updated Phase 1 Clinical Data for SYS-6002 (CRB-701) to be presented at 2024 ASCO Annual Meeting

GlobeNewswire 23:05 BioAtla Presenting Phase 1 Evalstotug Clinical Trial Data Demonstrating Clinical Benefit at the Upco...

GlobeNewswire 23:05 I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at A...

GlobeNewswire 23:05 Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrat...

GlobeNewswire 23:05 Cogent Biosciences Appoints Cole Pinnow as Chief Commercial Officer

GlobeNewswire 23:05 FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) ...

GlobeNewswire 23:05 NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Adva...

GlobeNewswire 23:05 Elcora Announces Share Consolidation

GlobeNewswire 23:05 Affimed Announces Positive Early Efficacy and Progression Free Survival Results of AFM24-102 Study i...

GlobeNewswire 23:04 Cullinan Therapeutics to Present First Data for CLN-619, a Novel Anti-MICA/B Antibody, in Combinatio...

GlobeNewswire 23:03 Promising Anti-tumor Activity of Novel Costimulatory Bispecific Antibody REGN7075 (EGFRxCD28) in Com...

GlobeNewswire 23:01 Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitab...

GlobeNewswire 23:01 Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluatin...

GlobeNewswire 23:01 HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical...

GlobeNewswire 23:00 Arvinas Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Co...

TeleTrader 23:00 Iran-backed militia claims drone attack on Eilat

GlobeNewswire 23:00 Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term E...

GlobeNewswire 23:00 Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual M...

GlobeNewswire 23:00 Merus Announces Publication of Abstracts for Presentation at the 2024 ASCO® Annual Meeting

Rodinia Oil Corp./ CA77487N1096 /

Herzlichen Dank für die Übermittlung Ihres geschätzten Feedbacks! Bitte hinterlassen Sie uns noch Ihre eMail Adresse, sofern Sie eine Rückmeldung von uns wünschen.